Indiana University School of Medicine leads a comprehensive program in Alzheimer's disease research spanning basic, translational and clinical research, focused on optimizing clinical care for patients with Alzheimer's disease. The school, ranked No. 6 in the nation for National Institute of Aging research, received $87 million in National Institutes of Health grants to fund Alzheimer's disease research. From developing the next generation of animal models and testing potential therapeutics to working alongside clinical research participants and patients in the state's largest health system, IU School of Medicine has a rich research program and expertise widely recognized around the world.
Basic and Preclinical Science
Basic scientists research the neurobiology and molecular genetics of Alzheimer’s disease to define disease mechanisms using animal models, identify therapeutic targets, rigorously test drugs and create molecules for potential drugs.
Clinical and Translational Science
Researchers in clinical and translational science test new methods to diagnose, treat and prevent Alzheimer’s disease, and advancing this research into improved diagnosis and care for patients living with the disease.
Clinical Innovation
Researchers in clinical and translational science test new methods to diagnose, treat and prevent Alzheimer’s disease, and advancing this research into improved diagnosis and care for patients living with the disease.
the latest news in alzheimer's research